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Introduction: 
 
Parkinson’s disease (PD) is a progressive 
neurological disorder caused by the loss of 
dopamine producing cells in the substantia 
nigra, which is located in the basal ganglia. 
As dopamine assists with transmitting and 
modulating signals in the brain, ongoing do-
pamine depletion causes motor, autonomic 
and cognitive impairments (Magrinelli et al., 
2016). PD is characterised by motor symp-
toms that are associated with movement 
(e.g. bradykinesia, rigidity, postural instabil-
ity, tremor) (Magrinelli et al., 2016), and non-
motor symptoms (e.g. mood/cognitive prob-
lems, depression, pain, sleep problems) 
(Schapira et al., 2017). Motor symptoms are 
considered the clinical manifestation of dopa-
mine insufficiency and used for PD diagnosis 
(Chenoweth, Sheriff, McAnally, & Tait, 2013; 
Queen, 2017; Schapira, Chaudhuri, & Jen-
ner, 2017). However, non-motor symptoms 
can become more debilitating than motor 
symptoms as PD progresses (Chenoweth et 
al., 2013; Schapira et al., 2017). 
 
A recent epidemiological study indicated up 
to 212,000 people (1 in 117 people aged 
over 50 years) are living with PD in Australia, 
with more than one million caregivers, family 
and friends directly impacted by the condition 
(Ayton et al., 2019).  
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The associated economic burden in 2014 
was almost $1.1 billion and accounted for 
53% of all health system costs (Deloitte Ac-
cess Economics, 2015); this burden is ex-
pected to rise. Nursing home and inpatient 
hospital care comprise the largest compo-
nent of these costs (Bohingamu Mudi-
yanselage et al., 2017; Deloitte Access Eco-
nomics, 2015; Oguh & Videnovic, 2012).  
 
The insidious onset, no known cure, and pro-
gressive nature of PD mean it is challenging 
to treat and requires a multidisciplinary ap-
proach (Bramble, Carroll, & Rossiter, 2018). 
In the inpatient context, a lack of specialist 
knowledge and low adherence to PD medi-
cation regimens can result in poor clinical 
outcomes such as extended recovery time, 
worsening symptoms, falls and morbidity 
(Cohen & Smetzer, 2015; Donizak & McCa-
be, 2017; Grissinger, 2018). These adverse 
events can result in longer hospital stay, re-
presentations and re-admissions, and in-
creased health system costs (Donizak & 
McCabe, 2017; Harris & Fry, 2017). Other 
concerns include shortfalls in the care provid-
ed and the lack of knowledge about PD in 
the healthcare team (Gill & Kitson, 2016). 
 
A recent Australian study by Harris and Fry 
(2017) suggested education and orientation 
programs should be more specific to PD and 
identified a need for evidence-based clinical 
guidelines to support earlier detection and 
management of PD in the inpatient setting. 
Greater collaboration among the healthcare 
team (including pharmacists) was also need-
ed to improve medication administration 
practices and avoid potential adverse events 
(Harris & Fry, 2017). It is important to identify 
a person with PD at presentation/admission 
to hospital so staff can be alerted to that per-
son’s particular needs (e.g. time-critical med-
ications). An early warning system means 
strategies can be implemented to ensure 
medications are available without delay 
(Aminoff et al., 2011; Gerlach, Winogrodzka, 
& Weber, 2011; Harris & Fry, 2017). This 
paper presents a collaborative clinical prac-
tice improvement project that was imple-
mented to raise awareness about PD among 
healthcare professionals, facilitate inter-
professional collaboration to address medi-
cation issues and improve the care journey 
for patients with PD. 
 
Project Background 
 
This collaborative project aimed to streamline 
hospital admission for individuals with PD by 
resolving identified problems. It also aimed to 
address increasing frustration and concerns 
among hospital staff and the local PD support 
group regarding care provision for patients 
with PD. Staff at the study hospital were also 
concerned about poor understanding of the 
complexity of PD (e.g. prolonged medication 
delays can be life threatening), extended 
length of hospital stay for patients with PD 
and reported adverse medication-related 
events. These concerns were consistent with 
issues reported in the literature (Donizak & 
McCabe, 2017; Oguh & Videnovic, 2012). 
 
In New South Wales (NSW), Australia, a part
-time Parkinson’s Clinical Nurse Consultant 
(CNC) services four hospitals (a 292-bed 
regional base hospital and three peripheral 
hospitals) along with nursing homes, commu-
nity visits and a multidisciplinary clinic, with-
out specific neurology support. This project 
was motivated by the Parkinson’s CNC in 
response to concerns raised by clinicians 
and consumers.  
 
Project Aim 
 
In the study hospital it was considered im-
portant to identify individuals with PD on 
presentation to the emergency department 
and improve staff knowledge and medication 
administration practices (Aminoff et al., 2011; 
Gerlach et al., 2011; Harris & Fry, 2017). 
Specifically, this project aimed to ensure that: 
individuals with PD presenting to the study 
hospital were identified within 4 hours of 
presentation/admission; essential medication 
was available in the emergency department; 
patients received medications on time; and 
contraindicated medications were not admin-
istered. The study outcomes included pa-
tient/carer satisfaction with medication man-
agement, reduced adverse events/incidents, 
and identification of individuals with PD on 
presentation to hospital. 
 
Methods: 
 
Following engagement with hospital and com-
munity stakeholders, a clinical practice im-
provement team was formed to address iden-
tified problems relating to effective PD care 
provision. The reporting of this study was 
consistent with the SQUIRE guidelines 
(Ogrinc et al., 2016). 
 
Project Setting and Implementation Team 
 
This project was conducted from September 
2015 to May 2018 at a regional teaching hos-
pital in New South Wales, Australia. The hos-
pital provides a range of services including 
emergency medicine, general medicine, sur-
gical, obstetric, paediatric, rehabilitation and 
intensive care services. Specialist services 
include an acute stroke unit, a coronary angi-
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ography unit, a renal unit, a mental health 
unit and oncology and radiotherapy services. 
The project was conducted in collaboration 
with the local Parkinson’s Support Group and 
Parkinson’s NSW. The multidisciplinary pro-
ject implementation team was recruited from 
across the study hospital (e.g. emergency, 
medical and surgical wards, and the hospital 
quality unit) and comprised a range of clini-
cians including doctors, nurses, a speech 
pathologist, a dietician, occupational thera-
pists, physiotherapists and pharmacists. The 
team was co-led by the CNC, an occupational 
therapist and a pharmacist, and supported by 
the hospital executive. The project team in-
cluded two members of the local PD support 
group to ensure consumer engagement 
throughout. 
 
Participants 
 
Purposive sampling was used to recruit par-
ticipants for the project-specific surveys. This 
sampling method captured individuals who 
had experienced the phenomenon under in-
vestigation (Yin, 2016). An opt-out method 
was used for hospital staff and patients/
carers that did not want to participate. Partici-
pants were directly approached and provided 
with information about the project. Two focus 
group discussions were held with members 
of the local PD support group, one before 
and one after project implementation (25–30 
people in each group). Focus group partici-
pants were identified and recruited through 
the support group coordinator. The inclusion 
criteria for the focus groups were member-
ship of the support group, and a diagnosis of 
PD or a carer for a person with PD. Those 
that were not members of the support group 
were excluded. 
 
The number of nurse participants ranged 
from 12–29, depending on the intervention 
measured. The inclusion criterion for nurse 
participants was nurses working in that ward/
unit. Survey completion was voluntary. In 
addition, patient/carer (n=16) satisfaction 
with medication management was assessed 
post-implementation using a short anony-
mous survey. Patient/carer participants were 
recruited during admission to hospital using 
convenience sampling. Patients/carers were 
eligible to participate if they had a length of 
stay >1 day. Discharged patients were ex-
cluded. Participants were informed that the 
survey was voluntary, and they could choose 
whether or not to participate.  
 
Interventions 
 
Specific interventions (discussed below) were 
introduced to address identified issues. The 
project followed the clinical practice improve-
ment methodology described by the NSW 
Clinical Excellence Commission, which offers 
a framework that allows clinicians to ‘review, 
identify and understand causes of the failure 
and design solutions to continuously improve 
processes of patient care’ (NSW Health, 
2019).  
 
The project process involved assessing the 
local context, Plan-Do-Study-Act cycles, audit 
and feedback, benchmarking and regular 
practice education support (Gill & Kitson, 
2016). This supported improved delivery of 
safe clinical care and enabled the team to 
build understanding of the underlying prob-
lems and gain insight into how to implement 
improvements. Clinical champions across the 
hospital were also used to educate others, 
advocate for change and translate new 
knowledge into routine clinical practice (Gill & 
Kitson, 2016; Mabey, 2013).  (See Figure 1). 
 
Grand Rounds  
 
To raise awareness of PD among hospital 
staff, education materials were developed 
through PD ‘Grand Rounds’. In this setting, 
Grand Rounds are weekly hospital-wide mul-
tidisciplinary education sessions. For this 
project, the Grand Rounds were filmed so all 
staff could access the education material. In 
the Grand Rounds, the multidisciplinary pro-
ject team provided education regarding the 
key points and interventions required for a 
person with PD when in hospital. The Grand 
Rounds also included a patient story to 
demonstrate improvements in care from one 
admission to the next. 
 
Alert System: PD Icon and Automated Refer-
ral to a Pharmacist 
 
A system was developed to alert emergency 
department staff to the arrival of patients with 
PD to support the project target of identifying 
patients with PD within 4 hours of presenta-
tion. Changes were made to the emergency 
department patient tracking board so a per-
son with PD was identified with a green PD 
icon. This was coupled with an automated 
notification system to alert the Parkinson’s 
CNC and initiate referral to the pharmacist.  
 
Medication Management 
 
Four strategies were developed to address 
identified medication issues. First, PD medi-
cations were made available in the emergen-
cy department to support administration of 
time-critical medications and avoid medica-
tion delays. This intervention aimed to en-
sure timely access to these medications, in-
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cluding after hours. Second, a pictorial alarm 
clock was introduced at the bedside to note 
critical medication times for inpatients. This 
was considered important as standard hospi-
tal medication round times may not match 
individualised medication plans for people 
with PD. Third, stickers for time-critical and 
contraindicated medications were developed 
for pharmacists to use on patients’ medica-
tion charts to remind staff and support the 
necessary practice change. These stickers 
provided visual cues to highlight the im-
portance of administering medications on 
time and identify the top three medications 
that should not be given to patients with PD. 
Finally, a clinical algorithm was developed to 
support switching a person’s medication 
when their ability to swallow was compro-
mised. 
 
Data Collection  
 
Qualitative data from the focus group discus-
sions were collected in field notes. The focus 
groups were facilitated by the hospital quality 
coordinator, who asked open-ended ques-
tions around hospital admission of patients 
with PD (e.g. ‘Taking PD medications while 
in hospital is important, can you tell me of 
your experiences with these medications in 
hospital?’). All focus group participants were 
encouraged to speak freely and openly. One 
focus group was held before project imple-
mentation and one was held post-
implementation. Information obtained from 
the first focus group assisted in developing 
the project interventions. The post-
implementation focus group provided oppor-
tunity for feedback on the interventions. Both 
focus groups were held in an accessible 
community venue and lasted around 60 
minutes. 
 
Quantitative data from nurses were collected 
via short self-administered paper-based sur-
veys designed by the project team. The sur-
veys were distributed after implementation of 
each intervention and collected nurses’ per-
ceptions of that intervention. For example, 
the survey distributed following PD medica-
tions being made available in the emergency 
department included questions such as ‘Has 
access to the medication been beneficial in 
providing patients their medications on time?’ 
Response options for items in all staff sur-
veys were ‘yes’, ‘no’ and ‘not applicable’. A 
free text area was provided so staff could 
offer any further comments. Before each sur-
vey, a member of the project team liaised 
with the nursing unit manager to advise them 
of the survey and seek their assistance in 
communicating with staff. The surveys were 
left on the ward/unit for nurses to complete 
on a voluntary basis. Completed surveys 
were returned via a confidential return box 
located on the ward/unit.  
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Data from patients/carers were collected us-
ing a paper-based survey (two items) admin-
istered post-implementation. One item as-
sessed if the patient had received their medi-
cations on time, with responses on a five-
point likert scale from ‘never’ to ‘always’. The 
second item evaluated patients’ satisfaction 
with their medication management, with re-
sponses on a five-point likert scale from ‘very 
satisfied’ to ‘very dissatisfied’. 
 
The chart audit monitored and evaluated 
changes in practice following the project im-
plementation. The audit was conducted be-
fore the project (January to June, 2016) and 
post implementation (September to Decem-
ber, 2016). Information collected covered: 
identification of a patient as having PD on 
admission; adverse events (e.g. aspiration 
pneumonia, falls, contraindicated medica-
tions given); current medications charted on 
admission; medications administered on time 
(yes/no/not documented); and pharmacist 
review after admission to the emergency de-
partment.  
 
In total, 22 charts were reviewed. The chart 
audit was conducted by the project team co-
leaders. Charts were included in the audit if 
they were for patients with a diagnosis of PD 
as determined by a neurologist, geriatrician 
or rehabilitation/medical physician, and iden-
tified in the hospital electronic medical record 
system or by hard copy records. In addition, 
length of stay data were collected from hos-
pital records for September 2015 
(commencement) and 2016 (the year after 
project commenced).  
 
Data Analysis 
 
Qualitative data obtained from the focus 
group discussions were analysed using the-
matic analysis. Quantitative data were ana-
lysed using descriptive statistics. Any survey 
questions with missing data were excluded 
from the analyses. The chart audit data rep-
resented approximately 20% of patient ad-
missions (the hospital admits >100 patients 
with PD each year), but no power calculation 
was used to determine the sample size. 
These data were entered into a Microsoft 
Excel spreadsheet, and descriptive statistics 
(frequencies and percentages) were calculat-
ed. Any missing data from the chart audit 
were managed by cross checking the data 
with paper/electronic medical records. 
 
Ethical Considerations 
 
As this was a quality improvement project, 
formal ethics approval was not required. 
However, approval to conduct the project 
was obtained from the study hospital execu-
tive. For nurse and patient/carer participants, 
return of a completed questionnaire was con-
sidered as provision of consent. All patient 
data were de-identified and aggregated be-
fore analysis. 
 
Results: 
 
The project interventions resulted in a num-
ber of improved outcomes. The qualitative 
data obtained from the focus groups are dis-
cussed first, followed by the main results for 
each of the interventions. 
 
Focus Group Discussions  
 
The main themes that emerged from the pre
-implementation focus group included medi-
cation management, basic care, the human 
factor and communication. Concerns were 
voiced about the inadequacies and shortfalls 
of the hospital system. These data were 
used to inform the project interventions. 
 
The post-implementation discussion provid-
ed opportunity to gather feedback from 
group members on the interventions. The 
main themes that emerged from this discus-
sion were increased awareness among hos-
pital staff of the specific needs of people with 
PD from the start of the care journey, the 
importance of medication timing and im-
provement in the overall care experience. 
The different comments made by participants 
in the first and second focus group discus-
sions reflected the interventions. For exam-
ple, a comment from the first focus group 
was:  
 
‘The staff in emergency don’t seem to 
know very much about Parkinson’s 
and the importance of medication tim-
ing; it took hours for the staff to get the 
medication from pharmacy for my hus-
band, and by the time he had it his 
symptoms were at their worst—very 
rigid and tremulous—and he was so 
anxious’.  
 
The feedback from the second focus group 
was markedly different: 
 
‘The staff in emergency and the 
wards have a very good understand-
ing of Parkinson’s. From the moment 
we presented to hospital, the staff 
knew my husband had Parkinson’s 
without even asking, the medications 
were given on time every time, much 
different from his other admission’. 
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Interventions: 
 
Staff Education: Grand Rounds 
 
The Grand Rounds lead by the multidiscipli-
nary project team focused on the key points 
and interventions required for a person with 
PD when in hospital. The session was filmed 
and uploaded to the health service’s elec-
tronic health education platform, which was 
available to all employees. The session was 
available for viewing by groups and on an 
individual basis. As at 16 March 2020, the 
production has been viewed 66 times. Alt-
hough formal feedback was not collected 
from staff, anecdotal evidence indicated that 
education provided, ‘a comprehensive over-
view of PD, the importance of medications on 
time and the care of patients when in hospi-
tal’.  A separate version of this education 
session was produced for the general public 
and broadcast twice via radio locally and 
around Australia, with the goal of raising pub-
lic awareness about PD.  
 
Alert System: PD Icon 
 
The target was to identify patients with PD 
within 4 hours of presentation to hospital. PD 
was first identified as a problem in the elec-
tronic medical records, and then tagged to 
the specific patient. An alert was triggered, a 
green ‘PD icon’ (Figure 2) displayed on the 
patient tracking board in the emergency de-
partment to identify a patient with PD.  
 
This resulted in marked improvement in iden-
tification of patients with PD. Post-
implementation, 100% of patients were iden-
tified on presentation to hospital (Table 1). 
This enabled earlier and increased referrals 
to pharmacists, which in turn helped to pre-
vent medication-related incidents. 
 
Figure 2. Parkinson’s disease tracking 
icon (red circle).  
Medication Management 
 
Four initiatives were implemented to improve 
clinical practice around the administration of 
medications to patients with PD. First, PD 
medications were made available in the 
emergency department to avoid medication 
delays. Post implementation, 100% of staff 
members were satisfied that this change had 
assisted in reducing medication delays and 
risk for medication errors (Table 1).  
 
Table 1. Summary of main pre- and post-
implementation differences (chart audit) 
The second medication management inter-
vention was the introduction of a pictorial 
alarm clock at the bedside to highlight critical 
medication times for inpatients (Figure 3).  
 
Figure 3: Medication management inter-
ventions. A: Pictorial alarm clock. B: 
Stickers for medication charts. 
Post-implementation, all staff (100%) report-
ed the clock had highlighted the importance 
of on-time medications (Table 2). In addition, 
93% of patients/carers reported they were 
satisfied that medications were received on-
time. The chart audit showed an increase in 
administration of PD medications on time 
from 44% at baseline to 63% post-
implementation (Table 1). 
 
Intervention Baseline Post-
implementation 
Identification of patients 
with PD within 4 hours of 
admission 
90% 100% 
Automated referral to 
pharmacist for patient 
review on admission 
27% 31% 
Prescription and admin-
istration of contraindicat-
ed medications 
44% 16% 
Contraindicated medica-
tions identified on medi-
cation charts (post-
implementation) 
- 94.7% 
PD medications adminis-
tered on time 44.4% 63.2% 
Time critical stickers used 
on medication charts 
(post-implementation) 
- 68.4% 
Australasian Journal of Neuroscience  Volume 30 ● Number 1 ● May 2020 
 38 
The third medication management initiative 
involved a newly introduced practice where 
stickers were placed on patients’ medication 
charts to highlight time-critical and contrain-
dicated medications (Figure 3). The chart 
audit following this initiative showed the ad-
ministration of contraindicated medications 
reduced from 44% at baseline to 16% post-
implementation (Table 1). After the introduc-
tion of these stickers, there was 68% compli-
ance with the time-critical stickers and 95% 
compliance with the contraindicated stickers 
(Table 1). Over the study period, the number 
of reported medication incidents was re-
duced from 11 to 5 (Table 3). In addition, 
100% of staff agreed the stickers highlighted 
the importance of on-time medications, and 
64% reported the initiative had resulted in 
changes to their practice (Table 2). 
 
Table 2. Nursing staff responses to the medication management intervention surveys  
  Yes 
n (%) 
No 
n (%) 
Not  
applicable 
n (%) 
Contraindicated sticker (N=24)       
Have you cared for a patient with Parkinson’s disease in 
the last 2 months? 
23 (95.8) 1 (0.4)   
Have you seen the contraindicated medication sticker? 16 (66.7) 8 (33.3)   
If yes, did the sticker highlight the importance of NOT 
administering the listed medications? 
16 (66.7) 0 8 (33.3) 
If yes, did the sticker result in a change of practice? 9 (37.5) 5 (20.8) 8 (33.3) 
Did you know that these commonly prescribed meds 
were contraindicated for people with PD? 
18 (75) 6 (25)   
Did the sticker result in a change of knowledge? 10 (41.6) 8 (33.3) 6 (25) 
Time-critical sticker (N=19)       
Have you seen the time critical sticker? 15 (78.9) 4 (21)   
If yes, did the sticker result in a change of knowledge? 5 (26.3) 10 (52.6) 4 (21) 
If yes, did the sticker result in a change of practice 5 (26.3) 10 (52.6) 4 (21) 
Are the stickers user friendly? 18 (94.7)   1 (5.3) 
Medications available in the ED (N=12)       
Are you aware that medications are available in the ED? 11 (91.7) 1 (8.3)   
If yes, were you able to identify the correct medication 
for the patient? 
9 (75)   3  (25) 
If yes, has access to the medication been beneficial in 
providing the correct medication for the patient? 
9 (75)   3 (25) 
Should these medications be available in the ED on a 
permanent basis? 
12 (100)     
Has the initiative raised your awareness of Parkinson’s 
disease? 
10 (83.3) 2 (16.7)   
Pictorial alarm clock (N=18)a       
Did the alarm clock highlight the importance of the need 
to administer the meds on time? 
18 (100)     
Did the alarm clock result in a change in practise? 8 (44.4) 7 (38.9) 3 (16.7) 
Is the alarm clock picture user friendly? 14 (77.8)     
ED, emergency department; PD Parkinson’s disease. 
aAlthough 29 nurses completed this survey, responses are only included for the 18 nurses who had 
seen the alarm clock because of missing data. 
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Finally, a clinical algorithm was developed 
and implemented to support switching a per-
son’s medication when their ability to swallow 
was compromised and they were nil by 
mouth (Figure 4). This was part of a clinical 
guideline that covered the changes imple-
mented throughout the project and aimed to 
standardise PD care in the study setting 
(Bramble et al., 2018; Gerlach et al., 2011; 
Harris & Fry, 2017). Formal and informal 
monitoring of guideline compliance was im-
plemented to ensure these changes were 
sustainable. Issues with non-compliance, 
patient and carer complaints and any report-
ed adverse events were discussed and peer 
reviewed during regular team meetings over 
the subsequent 12 months.  
 
In addition to the specific interventions noted 
above, the project contributed to a reduced 
average length of stay for patients with PD. 
Hospital records showed that in 2015, there 
were 101 episodes of care for secondary 
diagnoses of PD, with a mean length of stay 
of 8.97 days.  
 
Further Improvements: 
 
In 2016, there were 149 episodes of care for 
secondary diagnoses of PD, with a mean 
length of stay of 6.22 days (Table 3).  
Patients/carers expressed satisfaction with 
medication management (Table 4) following 
the interventions.  
 
Table 3. Medication incidents and length 
of hospital stay before and during the 
project period 
 
Focus group participants also reported satis-
faction with the improved care journey. Team 
facilitators were available to provide specific 
education to each ward as needed. This edu-
cation covered the components of the clinical 
  2015 2016 2017 
Number of pa-
tients with Parkin-
son’s disease 
admitted 
101 149 112 
Number of report-
ed medication 
incidents 11 6 5 
Length of hospital 
stay (days)a 
9 6 8 
Figure 4: Clinical algorithm for patients that are nil by mouth.  
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guideline, including identification of patients 
with PD, medication management (e.g. time-
critical PD medications, contraindicated med-
ications), and managing patients who were 
nil by mouth. 
 
Discussion: 
 
This paper presents a collaborative clinical 
practice improvement project that aimed to 
improve patient safety through reducing 
medication-related errors for patients with 
PD. More broadly, this project raised aware-
ness of PD among healthcare professionals, 
improved and standardised clinical practice 
in relation to provision of care for patients 
with PD and improved patients’ journey 
through care. 
 
The interventions focused on: a patient safety 
perspective that bridged departmental and 
professional barriers, continuation of exact 
personal medication regimens, identifying 
and avoiding contraindicated medications 
and alternatives for when a person was nil by 
mouth. These changes ensured on-time ad-
ministration of medications, which is thought 
to reduce symptom aggravation and risk for 
falls (Donizak & McCabe, 2017; Gerlach et 
al., 2011; Grissinger, 2018). 
 
Throughout this project, the team had to radi-
cally rethink their approach from the presen-
tation and admission of patients with PD by 
redefining and improving service delivery to 
meet the needs of patients with PD, their car-
ers and hospital management (Stalter & Mo-
ta, 2018). Both consumers and staff reported 
they were satisfied with the changes imple-
mented as a result of the project. After the 
project, patients with PD were identified 
100% of the time, and administration of med-
ications on time improved from 44%–63%, 
the ultimate goal to reach 100% with the pro-
posed introduction of an electronic medica-
tion management system. In addition, medi-
cation incidents and adverse events were 
reduced, with the team focused on reducing 
these events to zero.  
 
The practice changes that occurred in re-
sponse to this project became core business 
and were incorporated into a clinical guide-
line for the care and management of patients 
with PD at presentation and admission to 
hospital, with the aim of maintaining mean-
ingful long-term sustained change with im-
proved outcomes (Aminoff et al., 2011; Ger-
lach et al., 2011; Harris & Fry, 2017). These 
results are promising and reflect the recom-
mendations and conclusions of other re-
search relating to the care and management 
of patients admitted to hospital with PD 
(Aminoff et al., 2011; Chenoweth, Sheriff, 
McAnally, & Tait, 2013; Chou et al., 2011; 
Cohen & Smetzer, 2015; Donizak & McCabe, 
2017). 
 
The interventions, project process and 
changes in practice described in this paper 
have gathered interest in other healthcare 
settings (both nationally and internationally) 
following presentations at national (Carroll, 
2018a) and international (Carroll, 2018b) 
Item Responses 
  Always 
n (%) 
Sometimes 
n (%) 
No 
n (%) 
Don’t know 
n (%) 
Parkinson’s disease 
medications received 
on time? 
12 (80) 2 (13.3%) - 1 (6.7) 
  Dissatisfied 
n (%) 
Neither satisfied 
nor dissatisfied 
n (%) 
Somewhat 
satisfied 
n (%) 
Very satisfied 
n (%) 
Satisfaction with 
mediation 
management 
- - 3 (20) 12 (80) 
Free text comments 
(examples) 
‘I don’t know much about my medications, just a new diagnosis’ 
 
‘They were pretty good. Wife explained to hospital staff that it was 
important that the meds be given on time’ 
 
‘Different medication to what he has at home. In hospital he was given 
a white tablet where he has capsules at home’ 
Table 4. Patient/carer satisfaction (N=15) 
aThe categories ‘Very dissatisfied’ and ‘Somewhat dissatisfied’ have been combined in the table. 
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conferences. Key elements have been incor-
porated into the study hospital’s new Elec-
tronic Medication Management System 
(NSW Health, 2018), including electronic 
prompts for contraindicated and time-critical 
medications. Initiatives such as the time-
critical prompts were subsequently incorpo-
rated in the Rural Electronic Medication Man-
agement model across six Local Health Dis-
tricts in NSW. 
 
Other unintended outcomes following the 
project included the Parkinson’s CNC be-
coming a full-time role at the study institution 
and a second Parkinson’s CNC role being 
established in the region. Issues regarding 
provision of care for people with PD identified 
and addressed in this project highlighted the 
competencies required for the Parkinson’s 
CNC role (e.g. leadership, facilitation/
education skills, person-centred care, collab-
oration, evidence-based practice and quality 
improvement). The literature suggests that 
nurses who display strong leadership and 
facilitation skills can lead practice change, 
challenge systems and boundaries and im-
prove performance and standards (Stalter & 
Mota, 2018).  
 
Strengths and Limitations: 
 
A major strength of this project was the en-
gagement of a collaborative quality improve-
ment team to develop and lead the interven-
tions. The interventions introduced have 
proved to be simple, cost effective and easy 
to replicate, and staff and consumers ex-
pressed satisfaction with the changes. Limita-
tions of this project included the small sample 
size used for the chart audit (representing 
around 25% of admissions) and the staff sur-
veys. In addition, the project would have ben-
efited from statistical support, as no power 
calculation was used to determine sample 
sizes.  
 
Conclusion: 
 
This clinical practice improvement project 
showcases the benefits of a collaborative 
team approach to solving issues for people 
with PD presenting and admitted to hospital. 
The changes in practice described in this 
paper have been formalised in a clinical 
guideline to standardise PD care in the study 
setting.  
 
Broader Implications of the Project: 
 
In April 2018, the project co-leaders made a 
submission to NSW Health and Education 
Training Institute regarding implementation of 
state-wide PD education. This was success-
ful in June 2019 and resulted in a multimedia 
education project for nursing and allied 
health staff (NSW Health, 2020a). The Park-
inson’s CNC also collaborated with the NSW 
Health Clinical Excellence Commission in 
updating the NSW Health Safety Notice for 
management of medication for patients with 
Parkinson disease to guide actions by Local 
Health Districts/Networks (NSW Health, 
2020b).  
 
A collaborative research project has also 
been established to explore the effectiveness 
of the PD specialist nurse role for people with 
PD in the wider Australian context. Finally, 
the project was the catalyst for a three-stage 
research project commissioned by Parkin-
son’s NSW in collaboration with Charles 
Sturt University. Stage one involved develop-
ing evidence-based models to support best 
practice nursing services for people with PD 
in regional NSW (Bramble et al., 2018). 
Stage two comprised investigating a model 
of care for people living with PD and compar-
ing the impact of two specialist PD nurses in 
regional NSW (Rossiter, Bramble, Matheson, 
Carroll, & Phillips, 2019). A pilot retrospective 
analysis was also conducted to explore the 
cost effectiveness of specialist PD nurses, 
with the Parkinson’s CNC as the initiating 
researcher (Bramble, Wong, Rossiter, Car-
roll, & Schwebel, 2019). Stage three focuses 
on the role of community groups supporting 
people living with PD (Carroll, 2019). 
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